• Mon, February 5, 2024

by: WOPRAI

Jay Sole Maintained (VFC) at Hold with Decreased Target to $18 on, Feb 5th, 2024

by: WOPRAI

Joseph Feldman Reiterated (UAA) at Hold and Held Target at $9 on, Feb 5th, 2024

by: WOPRAI

Clay Griffin Downgraded (TTWO) to Hold on, Feb 5th, 2024

by: WOPRAI

Joe Ritchie Maintained (TT) at Hold with Increased Target to $287 on, Feb 5th, 2024

by: WOPRAI

Sung Ji Nam Maintained (TWST) at Buy with Increased Target to $43 on, Feb 5th, 2024

by: WOPRAI

Patrick Cunningham Maintained (APD) at Strong Buy with Decreased Target to $240 on, Feb 5th, 2024

by: WOPRAI

Scott Heleniak Maintained (AON) at Hold with Decreased Target to $325 on, Feb 5th, 2024

by: WOPRAI

Brian Meredith Maintained (AON) at Hold with Decreased Target to $308 on, Feb 5th, 2024

by: WOPRAI

Christopher Souther Maintained (AMRC) at Strong Buy with Decreased Target to $40 on, Feb 5th, 2024

by: WOPRAI

Christopher Souther Maintained (AMPS) at Strong Buy with Increased Target to $10 on, Feb 5th, 2024

by: WOPRAI

Erik Suppiger Maintained (ANET) at Buy with Increased Target to $325 on, Feb 5th, 2024

by: WOPRAI

Erik Suppiger Reiterated (AVNW) at Buy and Held Target at $50 on, Feb 5th, 2024

by: WOPRAI

Gabriela Borges Downgraded (BIGC) to Hold and Decreased Target to $9.5 on, Feb 5th, 2024

by: WOPRAI

Brian Wright Maintained (BG) at Strong Buy with Decreased Target to $138 on, Feb 5th, 2024

by: WOPRAI

Travis Steed Maintained (BDX) at Buy with Increased Target to $305 on, Feb 5th, 2024

by: WOPRAI

Kelly Shi Initiated (CABA) at Strong Buy and Held Target at $36 on, Feb 5th, 2024

by: WOPRAI

Kevin Caliendo Maintained (CAH) at Strong Buy with Increased Target to $125 on, Feb 5th, 2024

by: WOPRAI

Benjamin Budish Maintained (CBOE) at Buy with Decreased Target to $200 on, Feb 5th, 2024

by: WOPRAI

Andrew Bond Maintained (CBOE) at Strong Buy with Increased Target to $200 on, Feb 5th, 2024

by: WOPRAI

Owen Lau Maintained (CBOE) at Buy with Increased Target to $206 on, Feb 5th, 2024

by: WOPRAI

Manuel Navas Reiterated (CBFV) at Hold and Held Target at $24 on, Feb 5th, 2024

by: WOPRAI

Michael Zaremski Maintained (CB) at Hold with Increased Target to $240 on, Feb 5th, 2024

by: WOPRAI

Brian Meredith Maintained (CB) at Hold with Increased Target to $256 on, Feb 5th, 2024

by: WOPRAI

Jared Haase Initiated (ADUS) at Buy on, Feb 5th, 2024

by: WOPRAI

Suneet Kamath Maintained (AFL) at Hold with Decreased Target to $83 on, Feb 5th, 2024

by: WOPRAI

Brian Meredith Maintained (AXS) at Strong Buy with Increased Target to $80 on, Feb 5th, 2024

by: WOPRAI

Phil Hardie Maintained (BBU) at Buy with Increased Target to $28 on, Feb 5th, 2024

by: WOPRAI

Thiago Batista Maintained (BAP) at Strong Buy with Decreased Target to $190 on, Feb 5th, 2024

by: WOPRAI

Jed Kelly Maintained (BKNG) at Buy on, Feb 5th, 2024

by: WOPRAI

Lloyd Walmsley Maintained (BKNG) at Strong Buy on, Feb 5th, 2024

by: WOPRAI

Michael Swartz Maintained (WGO) at Strong Buy with Decreased Target to $82 on, Feb 5th, 2024

by: WOPRAI

Agnieszka Pustula Upgraded (WMG) to Hold and Held Target at $21 on, Feb 5th, 2024

by: WOPRAI

Vincent Colicchio Maintained (WNS) at Buy with Decreased Target to $72 on, Feb 5th, 2024

by: WOPRAI

Erik Suppiger Reiterated (VRNS) at Buy and Held Target at $63 on, Feb 5th, 2024

by: WOPRAI

Shagun Singh Reiterated (BSX) at Buy and Held Target at $70 on, Feb 5th, 2024

by: WOPRAI

Catharine Trebnick Reiterated (ZS) at Strong Buy and Held Target at $245 on, Feb 5th, 2024

by: WOPRAI

Alexander Potter Maintained (TSLA) at Buy with Decreased Target to $225 on, Feb 5th, 2024

by: WOPRAI

Lloyd Walmsley Maintained (TRIP) at Hold with Increased Target to $21 on, Feb 5th, 2024

by: WOPRAI

Lloyd Walmsley Maintained (TRVG) at Hold with Decreased Target to $2.25 on, Feb 5th, 2024

by: WOPRAI

Maggie Ye Initiated (TME) at Buy and Held Target at $11 on, Feb 5th, 2024

by: WOPRAI

Agnieszka Pustula Initiated (TME) at Strong Buy and Held Target at $12 on, Feb 5th, 2024

by: WOPRAI

Daniela Nedialkova Downgraded (TJX) to Hold and Held Target at $100 on, Feb 5th, 2024

by: WOPRAI

Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $29 on, Feb 5th, 2024

by: WOPRAI

Rick Wise Maintained (TNDM) at Hold with Increased Target to $24 on, Feb 5th, 2024

by: WOPRAI

Michael Binetti Upgraded (TPR) to Buy and Increased Target to $50 on, Feb 5th, 2024

by: WOPRAI

Balaji Prasad Maintained (TEVA) at Buy with Increased Target to $17 on, Feb 5th, 2024

by: WOPRAI

Nathan Rich Maintained (TEVA) at Hold with Increased Target to $11 on, Feb 5th, 2024

by: WOPRAI

Jason Celino Maintained (CDNS) at Buy with Increased Target to $325 on, Feb 5th, 2024

Rick Wise Maintained (TNDM) at Hold with Increased Target to $24 on, Feb 5th, 2024

Rick Wise of Stifel, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Increased Target from $17 to $24 on, Feb 5th, 2024.

Rick has made no other calls on TNDM in the last 4 months.



There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Mike Kratky of "Leerink Partners" Initiated at Hold and Held Target at $21 on, Monday, October 16th, 2023


This is the rating of the analyst that currently disagrees with Rick

  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Thursday, November 2nd, 2023

Like: 👍